Durvalumab vs Midazolam

## Durvalumab vs Midazolam: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Midazolam**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Midazolam**: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Midazolam — 1.5-2.5 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Midazolam — C18H13ClFN3.

**Molecular Weight**: Durvalumab — N/A; Midazolam — 325.7670 g/mol.

**Type**: Durvalumab — Antibody; Midazolam — Small molecule.